Influenza A virus vaccine (ACM biolabs/DIOSynVax)

N/A

Report date: 2025/06/03 15:46:04

Base Information

Drug NameInfluenza A virus vaccine (ACM biolabs/DIOSynVax)
Drug Alias NameInfluenza A virus H5NX vaccines
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingaporeUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesACM Biolabs Pte LtdDiosynvax Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDiosynvax LtdACM Biolabs Pte Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A